by John Conrad | Apr 27, 2020 | COVID, iBIO News
The response to the March 23rd launch of the iBIO COVID-19 PPE Response Fund has been enthusiastic and heartwarming. Every Monday, we will provide an update on the impact of the Illinois life sciences community and others who are offering their support to our state’s...
by John Conrad | Apr 20, 2020 | COVID, iBIO News
The response to the March 23rd launch of the iBIO COVID-19 PPE Response Fund has been enthusiastic and heartwarming. Every Monday, we will provide an update on the impact of the Illinois life sciences community and others who are offering their support to our state’s...
by John Conrad | Apr 7, 2020 | COVID, iBIO News
Since the March 23rd launch of the iBIO COVID-19 PPE Response Fund, the Illinois life sciences community is making a significant impact in the fight against the coronavirus. As of April 6th, the fund has received more than $760,000 in cash contributions and thousands...
by John Conrad | Apr 6, 2020 | COVID, Member News
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19 Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and...
by John Conrad | Apr 3, 2020 | COVID
Jim Cramer chats with outgoing Abbott Labs CEO Miles White and incoming CEO Robert Ford about the medical device maker’s development of a rapid coronavirus test that can provide results in minutes.